Scarica l'app Stockscreener
515.15
0.97%
-5.06
Dopo l'orario di chiusura:
515.15
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché IDXX Giù?
Forum
Previsione
Frazionamento azionario
Idexx Laboratories Inc Borsa (IDXX) Ultime notizie
IDEXX Laboratories (IDXX) director exercises options and sells 2,203 shares - Stock Titan
Idexx Laboratories stock hits 52-week low at $517.00 - Investing.com
Idexx Laboratories stock hits 52-week low at $517.00 By Investing.com - Investing.com India
IDEXX Laboratories stock heads into the open after a modest gain - ad-hoc-news.de
IDEXX Laboratories Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
IDEXX Laboratories stock holds near recent highs as diagnostics demand supports growth - ad-hoc-news.de
Down 16% in the Last 12 Months, Can IDEXX Stock Bounce Back in 2027? - TIKR.com
Veterinary Diagnostic Markets Report Now Available — See Exactly How IDEXX, Zoetis, Antech, Roche, and Thermo Fisher Are Positioned to Win Through 2030 - GlobeNewswire Inc.
IDEXX Laboratories, Inc. (IDXX) Stock Analysis: Exploring A 30% Upside Potential - DirectorsTalk Interviews
IDEXX Laboratories stock gains after strong Q2 results and raised 2026 outlook - ad-hoc-news.de
ETFs Investing in IDEXX Laboratories, Inc. Stocks - TradingView
IDXX: Idexx Laboratories Inc Latest Stock Price, Analysis, News and Trading Ideas - Stocktwits
IDEXX Laboratories Inc. stock outperforms competitors on strong trading day - MarketWatch
IDEXX Laboratories stock steadies after strong Q2 2026 results and raised outlook - AD HOC NEWS
IDEXX Laboratories Inc. stock underperforms Thursday when compared to competitors - MarketWatch
IDEXX Laboratories stock holds firm as investors eye earnings history - ad-hoc-news.de
Idexx (IDXX) Down 7.8% Since Last Earnings Report: Can It Rebound? - finance.yahoo.com
IDEXX Laboratories Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
IDEXX Laboratories stock holds firm after earnings beat - AD HOC NEWS
Resilient IDEXX Laboratories stock holds above $550 as earnings beat supports guidance - AD HOC NEWS
IDEXX Laboratories to Participate in Morgan Stanley 24th Annual Global Healthcare Conference - Yahoo Finance
IDEXX Laboratories Inc. stock outperforms competitors despite losses on the day - MarketWatch
IDEXX Laboratories Inc. (IDXX) Key Financial Ratios – Valuation, Profitability & More - Value Research
Are Wall Street Analysts Predicting IDEXX Laboratories Stock Will Climb or Sink? - barchart.com
Insider Decision: Andrew Emerson Exercises Options At IDEXX Laboratories For $101K - Benzinga
IDEXX (NASDAQ: IDXX) CFO exercises 265 options at $178.26 - Stock Titan
IDEXX Laboratories stock holds high valuation as earnings outlook firms - Ad-hoc-news.de
Is it a Prudent Move to Retain IDEXX Stock in Your Portfolio Now? - TradingView
IDEXX launches first dual-species point-of-care NT-proBNP test for cardiac disease in cats and dogs - DVM360
Rationale Behind Baron Focused Growth Fund’s IDEXX Laboratories (IDXX) Holding - Yahoo Finance
Flossbach Von Storch SE Invests $9.09 Million in IDEXX Laboratories, Inc. $IDXX - MarketBeat
Danske Bank A S Buys New Stake in IDEXX Laboratories, Inc. $IDXX - MarketBeat
BofA Securities Maintains IDEXX Laboratories Inc(IDXX.US) With Hold Rating, Raises Target Price to $665 - 富途牛牛
Resilient IDEXX Laboratories stock trades in the mid-$550s as investors weigh premium valuation and - Ad-hoc-news.de
IDXX (IDEXX Laboratories) Cash Flow from Operations : $1,372 Mil (TTM As of Jun. 2026) - GuruFocus
IDEXX Laboratories Inc. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
IDEXX Laboratories stock holds above the mid-$540s as valuation stays demanding - Ad-hoc-news.de
IDXX (IDEXX Laboratories) Cash From Discontinued Investing Activities : $0 Mil (TTM As of Jun. 2026) - GuruFocus
Tranche Update on IDEXX Laboratories, Inc.'s Equity Buyback Plan announced on August 13, 1999. - marketscreener.com
Plato Investment Management Ltd Takes $1.48 Million Position in IDEXX Laboratories, Inc. $IDXX - MarketBeat
IDEXX Labs Executing, But Valuation Continues To Weigh On That Execution (NASDAQ:IDXX) - Seeking Alpha
Weekly Recap: AI diagnostics expansion and Barclays trims target to $710 - TradingView
IDEXX Laboratories, Inc. (IDXX) Stock Analysis: Unpacking a 26.86% Potential Upside in the Diagnostics & Research Sector - DirectorsTalk Interviews
IDEXX Laboratories Inc (IDXX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Transamerica Large Core ESG's IDEXX Laboratories Inc(IDXX) Holding History - GuruFocus
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
IDXX Stock Price and Chart — NASDAQ:IDXX - TradingView
IDEXX Laboratories Inc. stock underperforms Friday when compared to competitors - MarketWatch
IDEXX Laboratories Targets $45B Pet Diagnostics Opportunity With AI, Cancer Tests - MarketBeat
IDEXX Laboratories, Inc. (IDXX) Analyst/Investor DaySlideshow (NASDAQ:IDXX) 2026-08-14 - Seeking Alpha
Handelsbanken Fonder AB Grows Position in IDEXX Laboratories, Inc. $IDXX - MarketBeat
IDEXX Laboratories, Inc. (IDXX) Stock forecasts - Yahoo Finance Singapore
IDEXX Laboratories Inc (IDXX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
IDEXX Laboratories, Inc. (IDXX) Stock Forecasts - Yahoo Finance
IDEXX Laboratories Launches Catalyst proBNP Test for In-Clinic Cardiac Disease Assessment - marketscreener.com
IDEXX launches in-clinic cardiac test for cats and dogs - Investing.com
IDEXX Expands Catalyst Platform into Cardiac Disease with First and Only Dual-Species Point-of-Care NT-proBNP Test - Eagle-Tribune
Barclays Adjusts Price Target on IDEXX Laboratories to $710 From $800, Keeps Overweight Rating - marketscreener.com
NewEdge Advisors LLC Acquires 5,761 Shares of IDEXX Laboratories, Inc. $IDXX - MarketBeat
1.43%
0.47%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):